How many clinical trials are there for Abdominal Neoplasms?

PlainTrial tracks 1 US clinical trials for Abdominal Neoplasms, of which 0 are currently recruiting.

Which interventions appear most often on Abdominal Neoplasms trial records?

Expect™19Flex needle (Boston Scientific Corp.,Natick,MA,USA) is the most-linked intervention name on Abdominal Neoplasms records (1 trial links). Names are sponsor-reported on ClinicalTrials.gov.

How do I find a recruiting trial for Abdominal Neoplasms?

Use the trial list filtered by Recruiting status, or visit the trial finder to search by condition and state. Always discuss with your healthcare provider.

Is this data current?

Data is from ClinicalTrials.gov. Trial status may have changed. Always verify at ClinicalTrials.gov before making participation decisions.

Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov enrollment closed small index

Abdominal Neoplasms clinical trials

Compiled by PlainTrial · August 8, 2026

A small indexed set (1 trial) with no open enrollment listed right now.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

Browse conditions → How counts are built

1 US clinical trials · none currently recruiting · #11,370 of 28,707 conditions by registered trial count

Abdominal Neoplasms: 1 US clinical trial tracked, none currently recruiting.

Abdominal Neoplasms is the subject of 1 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. The most active sponsor is Catholic University of the Sacred Heart, running 1 of these trials.

Enrollment posture brief

Registry condition abdominal-neoplasms

Volume-matched condition peers

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)

Open-enrollment share among volume-matched conditions near Abdominal Neoplasms

Abdominal Neoplasms has no open enrollment in this registry pull (1 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Abdominal Neoplasms on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

Abdominal Neoplasms is recruiting below its size-band peers.

0 of 1 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Indexed trials (enrollment closed)

1 total, page 1 of 1

COMPLETED NA 246 participants

EUS GUIDED Transduodenal Biopsy Using the 19G Flex

Catholic University of the Sacred Heart

NCT02307253

Phase Distribution

Phase data not available

Top Sponsors

Catholic University of the Sacred Heart 1 trials

Named interventions

Most-linked intervention names on Abdominal Neoplasms records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Expect™19Flex needle (Boston Scientific Corp.,Natick,MA,USA) Device

1 trials

US sites by state

Facility locations filed on Abdominal Neoplasms trials. A trial with sites in several states counts in each.

Indiana 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Abdominal Neoplasms page

1 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

No Abdominal Neoplasms trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
Catholic University of the Sacred Heart sponsors the most Abdominal Neoplasms trials on record, review their full trial history before evaluating a specific study. See Catholic University of the Sacred Heart's trials
Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Abdominal Neoplasms condition card totals 1 registered trials; most-linked intervention Expect™19Flex needle (Boston Scientific Corp.,Natick,MA,USA); top US site state Indiana. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.